Business Wire12h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
Don’t let seasickness stop you: expert tips for a smooth cruise experience
Let’s face it, seasickness is miserable. It can strike anyone, at any time, from those on their maiden voyage to the saltiest ...
Why alcohol's suddenly making middle-aged women sick. I used to love to drink... now I can't handle half a glass. And doctors have told me the astonishing reasons: A…
I was able to enjoy more than a drop of the hard stuff without much effect. But for several months now, the impact has been ...
TMCnet1d
Otolith Labs Announces Data Demonstrating Otolith Technology Effectiveness on Cybersickness from Virtual Reality in Exploratory Study
While the control group held expected relationships between perceived susceptibility and experienced motion sickness, neither ...